Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Medicines Company Reports Second Quarter Financial Results
The Medicines Company has announced its financial results for the second quarter of 2009, where net revenue increased by 20% to $104.2 million from $86.7 million for the
The Medicines Company has announced its financial results for the second quarter of 2009, where net revenue increased by 20% to $104.2 million from $86.7 million for the
Zila has amended the merger agreement with Tolmar Holding, a pharmaceutical research, development, manufacturing and commercial operations company, to reflect a higher price per share. Under the terms
Cardiome has received a $15 million milestone payment from its collaboration with Merck, through an affiliate. Reportedly, the milestone was triggered by the submission of a Marketing Authorisation
Shire has received a Complete Response letter for INTUNIV (guanfacine) Extended Release from FDA. Reportedly, FDA did not identify safety concerns regarding INTUNIV in the letter about the
Promius has launched Promiseb Topical Cream, a non-steroidal, prescription only, cream for the treatment of seborrheic dermatitis, that has demonstrated both anti-inflammatory and antifungal properties. Jeffrey Wasserstein, president
Wyeth has provided the data from a phase 3 clinical study. The results showed that the investigational compound – bazedoxifene/conjugated estrogens (BZA/CE), reduced the frequency and severity of
Watson Pharmaceuticals has reported net income of $53 million or $0.46 per diluted share for the second quarter of 2009, compared to $60.3 million or $0.53 per diluted
Boehringer Ingelheim has posted growth in local currency (+8.3%) in the first six months of 2009, as compared to the corresponding period previous year. The company reported net
BioAlliance Pharma SA has submitted the clinical trial application for Fentanyl Lauriad to the French Drug Agency (AFSSaPS). The company seeks the approval of this test by the
The Obesity Society has begun a five-year partnership with Healthy Interactions. The collaboration is aimed at developing educational materials using Healthy Interactions’ proprietary Conversation Map educational tools, to